PLASMA CELL DISORDERS
Clinical trials for PLASMA CELL DISORDERS explained in plain language.
Never miss a new study
Get alerted when new PLASMA CELL DISORDERS trials appear
Sign up with your email to follow new studies for PLASMA CELL DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to stop rare bone cancer from spreading
Disease control Recruiting nowThis phase 2 trial tests whether combining radiation with a bispecific antibody called CM336 can safely treat solitary bone plasmacytoma, a rare plasma cell tumor that often turns into multiple myeloma. The study will enroll 21 adults with mild bone marrow involvement. Researcher…
Matched conditions: PLASMA CELL DISORDERS
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 14:59 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThis study aims to detect multiple myeloma at its earliest stage, called MGUS, using a simple blood test. It will screen 1,665 Black adults and close relatives of people with plasma cell disorders. The goal is to reduce delayed diagnosis and improve outcomes by catching the disea…
Matched conditions: PLASMA CELL DISORDERS
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Mayo clinic launches gut bacteria study for rare plasma cell disorders
Knowledge-focused Recruiting nowThis study looks at the gut microbiome (the bacteria living in the digestive system) of people with POEMS syndrome, multiple myeloma, MGUS, AL amyloidosis, and healthy household members. Participants provide stool samples at home using a collection kit. The goal is to understand …
Matched conditions: PLASMA CELL DISORDERS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC